Macquarie Group
INSP icon

Macquarie Group’s Inspire Medical Systems INSP Stock Holding History

Macquarie Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,324
Closed -$3.21M – 1164
2025
Q3 		$3.21M Sell
43,324
-452,232
-91% -$45.8M ﹤0.01% 1045
2025
Q2 		$64.3M Sell
495,556
-62,671
-11% -$9.09M 0.08% 350
2025
Q1 		$88.9M Buy
558,227
+20,633
+4% +$3.73M 0.11% 262
2024
Q4 		$99.7M Sell
537,594
-44,726
-8% -$8.68M 0.12% 232
2024
Q3 		$123M Sell
582,320
-9,736
-2% -$1.69M 0.13% 213
2024
Q2 		$79.2M Buy
592,056
+33,571
+6% +$6.35M 0.09% 290
2024
Q1 		$120M Buy
558,485
+19,910
+4% +$3.9M 0.14% 198
2023
Q4 		$110M Sell
538,575
-65,031
-11% -$10.5M 0.13% 229
2023
Q3 		$120M Buy
603,606
+32,279
+6% +$8.14M 0.15% 183
2023
Q2 		$185M Sell
571,327
-27,740
-5% -$7.93M 0.21% 110
2023
Q1 		$140M Sell
599,067
-461,605
-44% -$117M 0.17% 160
2022
Q4 		$267M Sell
1,060,672
-347,241
-25% -$74M 0.32% 55
2022
Q3 		$250M Sell
1,407,913
-132,582
-9% -$26.6M 0.31% 63
2022
Q2 		$281M Buy
1,540,495
+14,017
+0.9% +$2.8M 0.32% 60
2022
Q1 		$392M Buy
1,526,478
+196,945
+15% +$45M 0.3% 57
2021
Q4 		$306M Buy
1,329,533
+256,762
+24% +$62.7M 0.25% 81
2021
Q3 		$250M Buy
1,072,771
+762,866
+246% +$159M 0.21% 97
2021
Q2 		$59.9M Buy
309,905
+242,689
+361% +$48.1M 0.05% 477
2021
Q1 		$13.9M Sell
67,216
-14,951
-18% -$3.18M 0.02% 635
2020
Q4 		$15.5M Sell
82,167
-17,569
-18% -$2.87M 0.02% 598
2020
Q3 		$12.9M Sell
99,736
-17,461
-15% -$1.92M 0.02% 585
2020
Q2 		$10.2M Sell
117,197
-16,986
-13% -$1.31M 0.02% 625
2020
Q1 		$8.09M Sell
134,183
-2,792
-2% -$207K 0.02% 609
2019
Q4 		$10.2M Buy
136,975
+11,187
+9% +$719K 0.01% 647
2019
Q3 		$7.68M Sell
125,788
-253
-0.2% -$16.7K 0.01% 657
2019
Q2 		$7.64M Buy
126,041
+46,026
+58% +$2.48M 0.01% 666
2019
Q1 		$4.54M Buy
80,015
+50,015
+167% +$2.7M 0.01% 806
2018
Q4 		$1.27M Hold
30,000
– – ﹤0.01% 1084
2018
Q3 		$1.26M Buy
+30,000
New +$1.41M ﹤0.01% 1146

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Macquarie Group's INSP Position: Q4 2025 in Review

Macquarie Group sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 43,324 shares — an estimated $3.21M sold.

Macquarie Group first reported a position in INSP in Q3 2018 and held it in 29 quarters. The position peaked at $392M in Q1 2022. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Macquarie Group reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 43,324 Inspire Medical Systems shares in Q4 2025, an estimated $3.21M.
  • Macquarie Group first reported a position in Inspire Medical Systems in Q3 2018 and held it in 29 quarters.
  • Macquarie Group's Inspire Medical Systems position peaked at $392M in Q1 2022.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.